权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

SBIR Phase I: Volition With An App

SBIR 第一阶段：通过应用程序决定

基本信息

批准号：
2026010
负责人：
Elizabeth La Rue
金额：
$ 25.59万
依托单位：
HERA GLOBAL TECH INC.
依托单位国家：
美国
项目类别：
Standard Grant
财政年份：
2020
资助国家：
美国
起止时间：
2020-08-01 至 2021-04-30
项目状态：
已结题

来源：
https://www.nsf.gov/awardsearch/showAward?AWD_ID=2026010&HistoricalAwards=false
关键词：
SBIR Phase Volition App

项目摘要

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project aims to decrease the number of overdose deaths in the U.S. by making an AI-driven mobile app to those suffering from substance use disorder (SUD). There were more than 67,000 drug overdose deaths in the U.S. in 2018. This project will potentially alter the existing behavioral health marketplace through its ability to save lives and reduce the $740 billion spent annually treating SUDs. The app, freely available to anyone with a mobile phone, uses an expert artificial intelligence (AI) system to suggest an appropriate evidence-based recovery plan to those in need. Medically recognized contingency-based therapy processes are incorporated to help individuals follow their recovery plans. This Small Business Innovation Research (SBIR) Phase I project will develop an expert system to develop an evidence-based personalized recovery program to individuals affected with SUD. To do this, the company is developing SUD self-directed recovery while enhancing compliance and motivation through a novel, salient reward system. Increasing recovery plan compliance is a major addition to current healthcare industry functions. The project will utilize a positive feedback loop via the novel use of value-based payment for individuals with substance use disorder with or without clinician oversight.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.

这个小企业创新研究（SBIR）第一阶段项目的更广泛的影响/商业潜力旨在通过为那些患有物质使用障碍（SUD）的人制作人工智能驱动的移动的应用程序来减少美国过量死亡的人数。2018年，美国有超过67，000例药物过量死亡。该项目将通过其拯救生命的能力改变现有的行为健康市场，并减少每年用于治疗SUD的7400亿美元。该应用程序免费提供给任何拥有移动的手机的人，使用专家人工智能（AI）系统向有需要的人建议适当的循证恢复计划。医学上认可的基于偶然性的治疗过程被纳入，以帮助个人遵循他们的恢复计划。这个小企业创新研究（SBIR）第一阶段项目将开发一个专家系统，为受SUD影响的个人开发基于证据的个性化恢复计划。为此，该公司正在开发SUD自我导向的恢复，同时通过一种新颖的、突出的奖励系统来增强合规性和动力。提高恢复计划合规性是当前医疗保健行业功能的一个重要补充。该项目将利用一个积极的反馈循环，通过新的使用价值为基础的支付个人与物质使用障碍与或没有临床医生的supervison.This奖项反映了NSF的法定使命，并已被认为是值得的支持，通过评估使用基金会的智力价值和更广泛的影响审查标准。